# Drug-Drug Interaction Study of MDR-001 With Rifampin and Itraconazole in Healthy Adult Participants

> **NCT07550621** · PHASE1 · NOT_YET_RECRUITING · sponsor: **MindRank AI Ltd** · enrollment: 28 (estimated)

## Conditions studied

- Healthy Volunteers (HV)

## Interventions

- **DRUG:** MDR-001
- **DRUG:** Rifampin
- **DRUG:** Itraconazole

## Key facts

- **NCT ID:** NCT07550621
- **Lead sponsor:** MindRank AI Ltd
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-05-06
- **Primary completion:** 2026-05-31
- **Final completion:** 2026-06-08
- **Target enrollment:** 28 (ESTIMATED)
- **Last updated:** 2026-04-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07550621

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07550621, "Drug-Drug Interaction Study of MDR-001 With Rifampin and Itraconazole in Healthy Adult Participants". Retrieved via AI Analytics 2026-06-16 from https://api.ai-analytics.org/clinical/NCT07550621. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*